Agonizing GABABR suppresses GLP-1RA's chronotropic effect and reduces post-myocardial infarction arrhythmogenesis

Run Qi1,2,3, Zhang Jingjing4,5,6, Gu Hongchang1,2

  • 1Department of Cardiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.

Frontiers in Pharmacology
|November 17, 2025
PubMed

Insights

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) impact heart rhythm via cardiac-autonomous mechanisms involving the GABAB receptor. GABABR activation counteracts GLP-1RA tachycardia but enhances anti-arrhythmic effects post-myocardial infarction.

Area of Science:

  • Cardiology
  • Neuropharmacology
  • Molecular Biology

Background:

  • Glucagon-like peptide-1 receptor agonists (GLP-1RAs) show cardiovascular benefits independent of glucose control.
  • The precise mechanisms by which GLP-1RAs influence cardiac rhythm remain incompletely understood and are a subject of ongoing research.
  • Investigating novel pathways is crucial for understanding GLP-1RA cardiovascular effects.

Purpose of the Study:

  • To elucidate the role of the GABAB receptor (GABABR) in mediating the chronotropic and anti-arrhythmic effects of GLP-1RAs.
  • To determine if GLP-1RA actions on heart rhythm are cardiac-autonomous or dependent on sympathetic input.
  • To explore the interaction between GABABR and GLP-1R signaling in the context of myocardial infarction (MI).

Main Methods:

  • Utilized a murine myocardial infarction model induced by left anterior descending artery ligation.
  • Generated cardiomyocyte-specific Gabbr1-knockout mice using adeno-associated virus serotype 9 (AAV9) delivery.
  • Assessed cardiac function and electrophysiology using Western blotting, immunofluorescence, in vivo electrophysiology, and patch-clamp recordings.
  • Investigated sympathetic influence via 6-hydroxydopamine (6-OHDA) treatment and sympathectomy.

Main Results:

  • GLP-1RA administration increased heart rate through a cardiac-autonomous pathway, independent of sympathetic nervous system activity.
  • GABABR activation attenuated GLP-1RA-induced tachycardia, while its deficiency exacerbated it.
  • GABABR agonism conferred enhanced resistance to ventricular arrhythmias following myocardial infarction in a GLP-1RA-dependent manner.
  • Patch-clamp studies indicated that semaglutide could suppress GABABR-induced repolarization in a dose-dependent manner.

Conclusions:

  • GABAB receptor activation counterbalances the chronotropic effects of GLP-1RAs.
  • GABABR activation synergistically enhances the anti-arrhythmic efficacy of GLP-1RAs in the post-myocardial infarction setting.
  • A novel interaction between GABABR and GLP-1R signaling pathways significantly impacts cardiac electrophysiology.
Abstract

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K